|
14 Feb 2025
|
3B BlackBio Dx
|
Edelweiss
|
1354.95
|
1920.00
|
1897.70
(-28.60%)
|
Target met |
Buy
|
|
|
Diagnostics business to see strong growth
|
|
13 Aug 2024
|
3B BlackBio Dx
|
Edelweiss
|
1354.95
|
1500.00
|
1275.75
(6.21%)
|
Target met |
Buy
|
|
|
Diagnostics business to see strong growth
|
|
31 May 2024
|
3B BlackBio Dx
|
Edelweiss
|
1354.95
|
1200.00
|
883.75
(53.32%)
|
Target met |
Buy
|
|
|
Diagnostics business to see strong growth
|
|
11 Sep 2023
|
3B BlackBio Dx
|
Edelweiss
|
1354.95
|
1184.00
|
840.30
(61.25%)
|
Target met |
Buy
|
|
|
Kilpest India (KLPI) has seen multiple transformations in the last ~50 years of existence.
|